SynBioBeta Speaker

Yue Webster

VP of Model-Driven Drug Discovery Platform

Lilly

May 2026, SynBioBeta

Speaker

Yue Wang Webster, PhD, MBA, has over 20 years of experience in the pharmaceutical industry. Currently serving as the Vice President of Model-Driven Drug Discovery at Eli Lilly, Yue leads a dynamic team dedicated to delivering cutting-edge technologies for drug discovery. Her team collaborates with scientists on both small molecule and large molecule projects, leveraging Agentic AI and large language models (LLM) to revolutionize drug discovery. Yue is well-versed in the challenges related to data and IT infrastructure, as well as practicalities of scaling AI innovations for enterprise-wide adoption.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

Previous Speakers Include

Join for the latest
SynBioBeta event updates.

Join for the latest SynBioBeta event updates.